Leveraging NMR and X-ray Data of the Free Ligands to Build Better Drugs Targeting Angiotensin II Type 1 G-Protein Coupled Receptor

Author(s): Tahsin F. Kellici , Dimitrios Ntountaniotis , Eftichia Kritsi , Maria Zervou , Panagiotis Zoumpoulakis , Constantinos Potamitis , Serdar Durdagi , Ramin Ekhteiari Salmas , Gizem Ergun , Ebru Gokdemir , Maria Halabalaki , Ioannis P. Gerothanassis , George Liapakis , Andreas Tzakos , Thomas Mavromoustakos .

Journal Name: Current Medicinal Chemistry

Volume 23 , Issue 1 , 2016

  Journal Home
Translate in Chinese

Abstract:

The angiotensin II type 1 receptor (AT1R) has been recently crystallized. A new era has emerged for the structure-based rational drug design and the synthesis of novel AT1R antagonists. In this critical review, the X-ray crystallographic data of commercially available AT1R antagonists in free form are analyzed and compared with the conformational analysis results obtained using a combination of NMR spectroscopy and Molecular Modeling. The same AT1R antagonists are docked and compared in terms of their interactions in their binding site using homology models and the crystallized AT1R receptor. Various aspects derived from these comparisons regarding rational drug design are outlined.

Keywords: Angiotensin II type 1 receptor antagonists, conformational analysis, NMR, molecular modeling, sartans, X-ray, GPCR, AT1R.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 23
ISSUE: 1
Year: 2016
Page: [36 - 59]
Pages: 24
DOI: 10.2174/0929867323666151117122116

Article Metrics

PDF: 64
HTML: 2
EPUB: 1
PRC: 1